Sugar Surprise: DNA Building Block Rivals Minoxidil in Reversing Hair Loss in Mice

 

A groundbreaking preclinical study has revealed that a simple, naturally occurring sugar—2-deoxy-D-ribose (2dDR), a fundamental component of DNA—can stimulate robust hair regrowth in a mouse model of androgenic alopecia (male-pattern baldness). Originally investigated for its ability to promote blood vessel formation and accelerate wound healing, 2dDR unexpectedly delivered results comparable to the gold-standard topical treatment minoxidil when formulated into a gel and applied to testosterone-induced bald patches.

The research, published in Frontiers in Pharmacology on June 3, 2024, builds on earlier observations that fur around 2dDR-treated skin wounds in mice grew back faster and thicker than expected.

This serendipitous finding prompted the team—led by scientists from COMSATS University Islamabad (Pakistan) and the University of Sheffield (UK)—to test the sugar directly against hereditary hair loss.Background: Why Hair Loss Happens and How Angiogenesis Could Help Androgenic alopecia (AGA) is the most common form of hair loss, affecting up to 80% of White men and significant portions of other populations by later adulthood. It is driven by the conversion of testosterone to dihydrotestosterone (DHT), which shortens the active growth (anagen) phase of hair follicles, pushes them into prolonged rest (telogen), and eventually miniaturizes them. Current FDA-approved treatments—minoxidil (which prolongs anagen and supports dermal papilla cells) and finasteride (which blocks DHT)—have limitations, including side effects, inconsistent long-term efficacy, and the need for continuous use.

A key biological factor in healthy hair growth is adequate blood supply. New blood vessel formation (angiogenesis) around follicles delivers oxygen, nutrients, and growth factors. Prior work by the same group showed that 2dDR is 80–90% as potent as vascular endothelial growth factor (VEGF) at stimulating vessel growth in lab and chick-embryo models. It also enhances endothelial cell proliferation, reduces cell death under low-oxygen conditions, and speeds wound closure in rats—without the high cost or instability of protein-based growth factors.

Study Design: Testing 2dDR in a Real-World Baldness Model Researchers used seven-week-old male C57BL/6 mice, a standard strain for hair cycle studies. Androgenic alopecia was induced by intraperitoneal testosterone injections (20 mg/kg, three times weekly for two weeks), followed by dorsal skin depilation under anesthesia. Six treatment groups (n=3–4 mice each) were established:

• Normal control (no testosterone, no treatment)
• Testosterone-only model (untreated baldness)
• Blank sodium alginate (SA) hydrogel (vehicle control)
• 2dDR-SA hydrogel (0.394% w/w 2-deoxy-D-ribose)
• 2% minoxidil spray (positive control)
• Combination: 2dDR gel + minoxidil

The hydrogel was a simple, biocompatible alginate-based formulation containing propylene glycol and phenoxyethanol for stability and skin compatibility. A precise 0.5 mL dose was applied topically once daily for 20 days. Progress was tracked with photographs, skin color scoring (pink to dark gray indicating regrowth), hair length/diameter measurements, and detailed histology.Key Result: The 2dDR gel triggered visible, thick hair regrowth within weeks — matching or closely approaching the minoxidil group.Key Results: Dramatic Regrowth and Structural Restoration Quantitative data confirmed:

• Hair length (guard hairs): Restored to 6.20 mm in the 2dDR group (vs. 6.04 mm in healthy controls and only 2.41 mm in untreated bald mice). Minoxidil achieved 6.19 mm.
• Hair shaft diameter: Increased to 198.6 µm with 2dDR (near-normal 204 µm), versus 138.8 µm in untreated mice.
• Follicle metrics (via H&E staining): Significant increases in follicle length, diameter, density, and anagen-to-telogen (A/T) ratio. More follicles re-entered the active growth phase.
• Blood vessel formation: Clear rise in the number of vessels surrounding follicles.
• Melanin coverage: Larger areas of melanin in hair bulbs, indicating healthier, more mature follicles.

Importantly, 2dDR performed at 80–90% the effectiveness of minoxidil across all measured parameters. Combining the two treatments offered no statistically significant extra benefit. No adverse effects were reported in the short-term study.

A minor corrigendum was issued in October 2024 correcting one figure panel; it does not affect any conclusions.Proposed Mechanism: Boosting Blood Supply to “Wake Up” Dormant Follicles The authors attribute the effects primarily to 2dDR’s well-documented pro-angiogenic properties. By promoting new blood vessel growth, the sugar improves nutrient and oxygen delivery to miniaturized follicles, enlarges hair bulbs, thickens shafts, and shifts the cycle back toward anagen. Additional support may come from reduced inflammation or direct effects on dermal papilla cells.Implications, Limitations, and the Road Ahead This is the first study to demonstrate 2dDR’s potential specifically for AGA. Its simplicity—a cheap, stable, naturally occurring sugar formulated into an easy-to-apply gel—could offer advantages over current options: lower cost, fewer side effects, and possible use in other forms of hair loss (e.g., chemotherapy-induced alopecia).However, results are limited to a testosterone-driven mouse model. Human skin and hair cycles differ significantly. Safety, optimal dosing, long-term efficacy, and potential systemic absorption in people have not been tested. Larger, longer preclinical work and human clinical trials will be essential.

News outlets have highlighted the findings as a “sweet surprise” and a potential boost for male-pattern baldness treatments, noting 2dDR’s natural occurrence in the body and its low-cost profile.Conclusion This research transforms an accidental observation from wound-healing studies into a promising new avenue for hair loss therapy. A DNA sugar that rivals minoxidil in mice could one day expand treatment options—offering hope for millions affected by patterned baldness. While human translation is still years away, the study underscores how simple biological molecules can yield unexpected therapeutic breakthroughs.

References & Further Reading

1. Anjum MA, Zulfiqar S, Chaudhary AA, et al. Stimulation of hair regrowth in an animal model of androgenic alopecia using 2-deoxy-D-ribose. Frontiers in Pharmacology. 2024;15:1370833. Read the full open-access paper (with corrigendum).
2. University of Sheffield. Cure for male pattern baldness given boost by sugar discovery. July 16, 2024. Read university press release.
3. MedicalXpress. Cure for male pattern baldness given boost by sugar. July 22, 2024. Read full article.
4. ScienceAlert. Surprise Hair Loss Breakthrough: Sugar Gel Triggers Robust Regrowth. July 25, 2024. Read coverage.

---